Results 241 to 250 of about 36,696 (303)

QTc Interval and Its Associated Factors in Patient With Type 2 Diabetic Mellites. [PDF]

J Diabetes Res
Asmare DS, Abebe TA, Ashenef B, Baylie T, Shita Y.   +4 more
europepmc   +1 more source

Drug Prescribing Patterns in Geriatric Patients With Type 2 Diabetes Mellitus at a Tertiary Care Teaching Hospital: A Cross-Sectional Study. [PDF]

Cureus
Gupta D, Sharma A, Hussain S, Sawlani KK, Katiayar D, Usman K, Nath R.   +6 more
europepmc   +1 more source

Influence of soil applied insecticide terbufos on selectivity of sulfonylurea herbicides towards maize [PDF]

, 2009
Goran Malidža, Ibrahim Elezović, Janjić Vaskrsija, Vrbničanin Sava   +3 more
openalex  

Evaluation of potential approaches for counting person-time in instances where no active comparator is present. [PDF]

Am J Epidemiol
Giorgio K, Lutsey PL, Wang W, Walker R, Norby FL, Huling J.   +5 more
europepmc   +1 more source

Antidiabetic sulfonylureas: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices

, 1989
Christiane Mourre, Yehezkel Ben‐Ari, Henri Bernardi, Michel Fosset, Michel Lazdunski   +4 more
openalex   +2 more sources

Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes.

JAMA Netw Open
Neugebauer R, An J, Dombrowski SK, Oshiro C, Cassidy-Bushrow A, Gilliam L, Simonson G, Karter AJ, Bergenstal R, Finertie H, Yassin MM, Knowlton G, Lin SR, Dyer W, Pimentel N, Izadian K, Schmittdiel J, Thomas TW, Hooker SA, Nolan MB, Wright E, Aurora L, Rodriguez LA, Kaur J, Adams AS, van der Laan MJ, O'Connor PJ.   +26 more
europepmc   +1 more source

The role of membrane excitability in pancreatic β-cell glucotoxicity [PDF]

, 2019
Nichols, Colin G., Remedi, Maria S., Shyr, Zeenat A., Wang, Zhiyu, York, Nathaniel W.   +4 more
core   +1 more source

Unraveling the Genetic Links: The Impacts of Antidiabetic Drugs on Stroke Risk. [PDF]

Rev Cardiovasc Med
Chen J, Wang YZ, Li LC, Xu J.
europepmc   +1 more source

Effects of glucagon-like peptide-1 receptor agonists on psychiatric disorders: a systematic review. [PDF]

Ther Adv Psychopharmacol
Lee S, Yin L, Teopiz KM, Wong S, Han Le G, Xiao N, Stahl S, Valentino K, Ho R, Zhang MC, Greg Rhee T, McIntyre RS.   +11 more
europepmc   +1 more source

Comparative Efficacy, Safety, and Cost-Utility of DPP-4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real-World Clinical and Economic Outcomes. [PDF]

J Diabetes Res
Jimoh AO, Hudu SA, Sabir AA, Adamu AA, Bello N, Tahir A, Abubakar N.   +6 more
europepmc   +1 more source